IL6 and COVID-19: A study of 74 COVID-19 patients reported that surviving patients had significantly higher H2S levels than non-survivors, and that serum H2S levels negatively correlated with serum IL-6, CRP, and procalcitonin (markers for bacterial infection, sepsis, and tissue injury) (Renieris et al., 2020).